Title |
Analgesic effects of NB001 on mouse models of arthralgia
|
---|---|
Published in |
Molecular Brain, October 2015
|
DOI | 10.1186/s13041-015-0151-9 |
Pubmed ID | |
Authors |
Zhen Tian, Dong-sheng Wang, Xin-shang Wang, Jiao Tian, Jing Han, Yan-yan Guo, Bin Feng, Nan Zhang, Ming-gao Zhao, Shui-bing Liu |
Abstract |
Our previous studies have demonstrated the critical roles of calcium-stimulated adenylyl cyclase 1 (AC1) in the central nervous system in chronic pain. In the present study, we examined the analgesic effects of NB001, a selective inhibitor of AC1, on animal models of ankle joint arthritis and knee joint arthritis induced by complete Freund's adjuvant injection. NB001 treatment had no effect on joint edema, stiffness, and joint destruction. Furthermore, the treatment failed to attenuate the disease progression of arthritis. However, NB001 treatment (3 mg/kg) significantly weakened joint pain-related behavior in the mouse models of ankle joint arthritis and knee joint arthritis. Results indicated that NB001 exhibited an analgesic effect on the animal models of arthritis but was not caused by anti-inflammatory activities. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 16 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 5 | 31% |
Student > Ph. D. Student | 3 | 19% |
Student > Doctoral Student | 1 | 6% |
Lecturer > Senior Lecturer | 1 | 6% |
Other | 1 | 6% |
Other | 1 | 6% |
Unknown | 4 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 31% |
Agricultural and Biological Sciences | 3 | 19% |
Neuroscience | 2 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Nursing and Health Professions | 1 | 6% |
Other | 0 | 0% |
Unknown | 4 | 25% |